RGS RGS Healthcare Solutions

Guide

How to estimate tender volumes when they are not stated

Published 2026-11-04 · Updated 2026-11-16 · RGS Healthcare Solutions

Short answer: Treat any volume in a tender as a starting point. Many buyers publish estimates, frame volumes as maximums, or leave them out. A better estimate combines the stated figure with the contract value and unit price, earlier rounds, the number of partners per lot and actual consumption, and keeps stated and estimated volume visibly separate.

Why stated volumes mislead

Volumes in tenders are often indicative. Frameworks state maximum quantities, multi-partner awards split volume between suppliers, and some buyers publish no quantity at all. Planning production or pricing on the stated figure alone can be badly wrong in either direction.

Inputs for a better estimate

  1. The stated quantity and how the buyer describes it: estimate, maximum or commitment.
  2. Contract value divided by the unit price, where both are published.
  3. The volume of earlier rounds for the same buyer and molecule.
  4. The number of partners sharing the lot and how volume is split.
  5. Actual consumption of the molecule in that market.

Show estimates next to stated figures, never instead

An estimate is only useful if people know it is one. Keep stated and estimated volume in separate columns, say how each estimate was made, and only show averages where enough tenders stand behind them.

Questions

Are volumes in pharmaceutical tenders binding?

Usually not. Many tenders state estimated or maximum quantities, and multi-partner awards split volume between suppliers, so the volume a supplier actually delivers can differ widely from the stated figure.

How each market does it

Terms used in this guide

See the answer on your own molecules

We load your products and markets before the demo, and show the results for them.